Camp4 Therapeutics Corp Quarterly Operating Income (Loss) in USD from Q3 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Camp4 Therapeutics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q3 2023 to Q2 2025.
  • Camp4 Therapeutics Corp Operating Income (Loss) for the quarter ending June 30, 2025 was -$13M, a 2.89% decline year-over-year.
  • Camp4 Therapeutics Corp Operating Income (Loss) for the twelve months ending June 30, 2025 was -$53.7M.
  • Camp4 Therapeutics Corp annual Operating Income (Loss) for 2024 was -$53.1M, a 2.33% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$53.7M -$13M -$366K -2.89% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$53.3M -$13.1M -$225K -1.75% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$53.1M -$14M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$13.5M -$1.18M -9.55% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-21
Q2 2024 -$12.7M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$12.9M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q3 2023 -$12.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.